Professional article
English

Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy

Published in

Journal of clinical pathology, vol. 60, no. 2, p. 185-189

Publication date

2007

Abstract

Prognostic factors in predicting outcomes in patients with head and neck squamous-cell carcinoma (HNSCC) are limited to the clinical-pathological parameters, including lymph node metastasis, location, grade and stage of the disease.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell/metabolism/pathology/radiotherapy
  • Cytoskeletal Proteins/metabolism
  • Disease-Free Survival
  • Female
  • Genes, Tumor Suppressor
  • Head and Neck Neoplasms/metabolism/pathology/radiotherapy
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • NM23 Nucleoside Diphosphate Kinases
  • Neoplasm Proteins/metabolism
  • Nucleoside-Diphosphate Kinase/metabolism
  • Prognosis
  • Retrospective Studies
  • Serpins/metabolism
  • Treatment Outcome
  • Tumor Markers, Biological/metabolism

Citation (ISO format)

MHAWECH-FAUCEGLIA, Paulette et al. Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. In: Journal of clinical pathology, 2007, vol. 60, n° 2, p. 185–189. doi: 10.1136/jcp.2006.036624

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0021-9746
627views
0downloads

Technical informations

Creation

10/10/2012 19:22:00

First validation

10/10/2012 19:22:00

Update

14/03/2023 19:59:48

Status update

14/03/2023 19:59:47

Last indexation

30/10/2024 08:37:16
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated